Leadership Presentation · Mike Nagel, CEO
Bringing oxygen visibility to fetal monitoring.
Mike Nagel describes the uncertainty clinicians face when fetal heart rate monitoring is indeterminate and explains how fetal pulse oximetry could add objective oxygen information during labor. He outlines Raydiant’s two complementary platforms and the company’s clinical development strategy.
- Nirah: a direct fetal pulse oximetry platform designed for real-time oxygenation information during labor.
- Lumerah: a non-invasive, transabdominal platform using advanced biophotonics and machine learning.
- Clinical integration: technology designed to work with existing fetal monitors and support data-informed decision-making.
- Development momentum: clinical studies, FDA engagement, grant support, and a development collaboration with GE HealthCare.